Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT05193617 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05193617
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2025-01-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.